Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype. (Q40456671)
Jump to navigation
Jump to search
scientific article published on 5 January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype. |
scientific article published on 5 January 2005 |
Statements
1 reference
Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype. (English)
1 reference
Su-Jun Lee
1 reference
Burhan Ghanayem
1 reference
Joyce A Goldstein
1 reference
5 January 2005
1 reference
1 reference
313
1 reference
1
1 reference
302-309
1 reference
Identifiers
1 reference
1 reference